Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound
Patent
1992-10-30
1994-05-17
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Sulfur, selenium or tellurium compound
568 37, C07C31710, A01K 31557
Patent
active
053128427
ABSTRACT:
The present invention relates to cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-aliphatic or arylaliphatic derivatives. In particular, heptenylsulfinylmethyl and heptanylsulfinylmethyl 2-aliphatic or arylaliphatic derivatives, substituted at the 3 and/or 5 position of the cyclopentane ring with radicals selected from the group consisting of hydroxy, alkylcarboxy and mixtures thereof, are disclosed. These compounds are useful as ocular hypotensives.
REFERENCES:
patent: 4171331 (1979-10-01), Biddlecom
patent: 4599353 (1986-07-01), Bito
patent: 4994274 (1991-02-01), Chan et al.
patent: 5028624 (1991-07-01), Chan et al.
patent: 5034413 (1991-07-01), Chan et al.
Starr, M. "Further Studies on the Effect of Prostaglandin on Intraocular Pressure in the Rabbit", Exp. Eye Res., 1971, 11, 170-177.
Bito, L. Z., "Prostaglandins and Related Compounds as Potential Ocular Therapeutic Agents":, Cohen, M. M., ed., Biological Protection with Prostaglandins, 1985, pp. 231-252, Boca Ratan, Fla.
Bito, L. Z., "Prostaglandins, Other Eicosanoids, and Their Derivatives as Potential Antiglaucoma Agents":, Applied Pharmacology in the Medical Treatment of Glaucoma, 1984, pp. 477-505, New York.
Nilsson, et al., "Increases Uveoscleral Outflow", Invest. Ophthalmol. Vis. Sci. 28 (suppl), 284, 1987.
Bito, L. Z., "Prostaglandins, Old Concepts and New Perspectives", Arch. Ophthalmol. 105, 1036, 1987.
Siebold, et al., "Esterified prostaglandin shows `potent` promise", Prodrug 5, 3, 1989.
Allergan Inc.
Baran Robert J.
Gerstl Robert
Lambert Howard R.
Voet Martin A.
LandOfFree
Cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-877087